| Market revenue in 2025 | USD 105.6 million |
| Market revenue in 2033 | USD 197.9 million |
| Growth rate | 8.3% (CAGR from 2026 to 2033) |
| Largest segment | Epigenetic age testing |
| Fastest growing segment | Multi-Omics Profiling |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Epigenetic Age Testing, Telomere Length Analysis, Multi-Omics Profiling, Proteomics-Based Aging Biomarkers, Metabolomics Testing, Microbiome Aging Diagnostics, Hormone & Metabolic Profiling |
Publish Date: May 12, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| 23andMe Holding Co Class A | View profile | 816 | 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 | www.23andme.com |
| Knovos | View profile | 251-500 | Fairfax, Virginia, United States, North America | www.knovos.com/ |
| Nebula Genomics | View profile | 11-50 | San Francisco, California, United States, North America | www.nebula.org |
| Abbott | View profile | - | - | - |
| Elysium | View profile | 11-50 | New York, New York, United States, North America | www.elysiumhealth.com |
| SiPhox Health | View profile | 11-50 | Burlington, Massachusetts, United States, North America | siphoxhealth.com |
| TruDiagnostic | View profile | 51-100 | Lexington, Kentucky, United States, North America | trudiagnostic.com |
| GlycanAge | View profile | 11-50 | Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom, Europe | glycanage.com |
| Tally Health | View profile | 11-50 | New York, New York, United States, North America | www.tallyhealth.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Longevity Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Epigenetic Age Testing was the largest segment with a revenue share of 27.65% in 2025.
Horizon Databook has segmented the India longevity diagnostics market based on epigenetic age testing, telomere length analysis, multi-omics profiling, proteomics-based aging biomarkers, metabolomics testing, microbiome aging diagnostics, hormone & metabolic profiling covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of country-level data and insights on the India Longevity Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Longevity Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
